Cargando…

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET

We have applied boron neutron capture therapy (BNCT) for 46 recurrent high grade meningiomas (HGM). Twelve cases among them, fluoride-labeled boronophenylalanine positron emission tomography (18F-BPA-PET) were utilized before and after BNCT to evaluate the tumor activity. The lesion to normal brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takai, Satoshi, Matsushita, Yoko, Kawabata, Shinji, Ono, Koji, Isohashi, Kayako, Wanibuchi, Masahiko, Miyatake, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699087/ http://dx.doi.org/10.1093/noajnl/vdaa143.055

Ejemplares similares

RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021)

ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019)

5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
por: Fukumura, Masao, et al.
Publicado: (2023)

Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
por: Morris, G. M., et al.
Publicado: (1997)

Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine
por: Kondo, Natsuko, et al.
Publicado: (2020)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

TB-03 THE SURVIVAL PROLONGATION EFFECT OF NOVEL BORON COMPOUND FOR BNCT USING RAT BRAIN TUMOR MODEL
por: Fukuo, Yusuke, et al.
Publicado: (2019)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

TB-6 Experimental evaluation of the therapeutic potential of boron neutron capture therapy in primary central nervous system lymphoma
por: Yoshimura, Kohei, et al.
Publicado: (2021)

10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT
por: Miyatake, Shin-Ichi, et al.
Publicado: (2020)

ET-4 BASIC RESEARCH OF BORON NEUTRON CAPTURE THERAPY USING A NOVEL BORON COMPOUND TARGETED TO INTEGRIN
por: Tsujino, Kohei, et al.
Publicado: (2022)

Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation
por: Yoshimura, Kohei, et al.
Publicado: (2021)

Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model
por: Lin, Yu-Chuan, et al.
Publicado: (2022)

NI-04 WHICH RADIOLOGICAL IMAGING IS BEST TO DISCRIMINATE RADIATION NECROSIS FROM TUMOR PROGRESSION? - SUBANALYSIS OF SYSTEMATIC REVIEW FOR RADIOLOGICAL DIAGNOSIS OF RADIATION NECROSIS
por: Furuse, Motomasa, et al.
Publicado: (2019)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

Biodistribution of Boron Concentration on Melanoma‐bearing Hamsters after Administration of p‐, m‐, o‐Boronophenylalanine
por: Hiratsuka, Junichi, et al.
Publicado: (2000)

Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo-Dodecaborate on a Rat Brain Tumor Model
por: Fujikawa, Yoshiki, et al.
Publicado: (2023)

Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system
por: Hu, Naonori, et al.
Publicado: (2021)

RT-5 Boron Neutron Capture Therapy has extended progression-free survival about recurrent malignant peripheral nerve sheath tumor - A case report
por: Watanabe, Yuko, et al.
Publicado: (2021)

Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model
por: Tsujino, Kohei, et al.
Publicado: (2023)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using (10)B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
por: Fukuda, Hiroshi
Publicado: (2021)

Analyzing spatial distribution between (18)F-fluorodeoxyglucose and (18)F-boronophenylalanine positron emission tomography to investigate selection indicators for boron neutron capture therapy
por: Nakaichi, Tetsu, et al.
Publicado: (2022)

The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model
por: Takahara, Kiyoshi, et al.
Publicado: (2015)

ET-5 Biological effects of simultaneous use of multiple drugs in neutron capture therapy using rat brain tumor model
por: Kawabata, Shinji, et al.
Publicado: (2021)

Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor
por: Liu, Yong, et al.
Publicado: (2013)

Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism
por: Nomoto, Takahiro, et al.
Publicado: (2020)

Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
por: Hiramatsu, Ryo, et al.
Publicado: (2013)

Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model
por: Kashiwagi, Hideki, et al.
Publicado: (2023)

FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model
por: Hanaoka, Kohei, et al.
Publicado: (2014)

Boron Neutron Capture Therapy and Photodynamic Therapy for High-Grade Meningiomas
por: Nakahara, Yukiko, et al.
Publicado: (2020)

Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma
por: Lan, Tien-Li, et al.
Publicado: (2023)

Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan
por: Matsumura, Akira, et al.
Publicado: (2023)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

Evaluation of Pharmacokinetics of Boronophenylalanine and Its Uptakes in Gastric Cancer
por: Tang, Futian, et al.
Publicado: (2022)

Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
por: Futamura, Gen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ebha4bno5cnhgfik53k9h1da7g